Assessment of Diaphragmatic Mobility in Dyspneic Patients With Different Types of Interstitial Lung Diseases
NCT ID: NCT07131072
Last Updated: 2025-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2021-02-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
recent study using lung ultrasound in assessment of diaphragmatic mobility in IPF patients and found that Diaphragmatic mobility is lower in IPF patients than in healthy controls, especially during deep inspiration. The correlation between reduced FVC and diaphragmatic excursion values in IPF patients can be of interest, since it could represent an index of functional respiratory affection performed by chest ultrasound
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Diaphragm in Chronic Obstructive Pulmonary Disease Patients by Ultrasound in Relation to Severity
NCT05035875
Diaphragmatic Motion Using Linear Ultrasound
NCT03225508
Trans Thoracic Ultrasound to Assess Diaphragmatic Function in Stable COPD Versus Bronchial Asthma.
NCT06348745
The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases
NCT01225367
Transthoracic Ultrasonography Findings and Their Relation to Spirometric Indices in Patients With Obstructive and Restrictive Respiratory Diseases
NCT05175313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Studies have supported the advantage of ultrasonography in the assessment of diaphragmatic mobility by two-dimensional (BD) or M-mode. Others reported the investigation methods, the criteria for normal and pathological diaphragmatic function, and the perspectives of development in adult patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
collagen related interstitial lung disease
daiphragm mobility by ultrsound
fibrosis score, alveolitis score by CT Chest
spirometry ,DLCo
FEV1, FVC, FEV1/FVC, DLCo
idiopathic type (IPF)
daiphragm mobility by ultrsound
fibrosis score, alveolitis score by CT Chest
spirometry ,DLCo
FEV1, FVC, FEV1/FVC, DLCo
OTHERS(occupational,sarcoid,...)
daiphragm mobility by ultrsound
fibrosis score, alveolitis score by CT Chest
spirometry ,DLCo
FEV1, FVC, FEV1/FVC, DLCo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
daiphragm mobility by ultrsound
fibrosis score, alveolitis score by CT Chest
spirometry ,DLCo
FEV1, FVC, FEV1/FVC, DLCo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with end stage organ failure e.g.: Renal failure, liver cell failure
* Patients with malignancy elsewhere.
* The patients who refuse to be entitled in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hieba gamal ezz-elragal awad
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU R13/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.